Incorporating Data Integrity into Your Pharmaceutical Quality Management System
Source: Parenteral Drug Association (PDA)
By Anthony Warchut, Vice President, Technical, PAREXEL
ICH Q10, Pharmaceutical Quality Systems was recommended for adoption to the regulatory bodies of the European Union, Japan and the United States in 2008. EMA then formally approved it that same year. In 2009, the U.S. FDA adopted it as a guidance document. This begs the following question, if companies have adopted the principles of ICH Q10, why have the FDA and EMA been experiencing an increase in the number of data integrity issues found during recent inspections?
access the Article!
Log In
Get unlimited access to:
Trend and Thought Leadership Articles
Case Studies & White Papers
Extensive Product Database
Members-Only Premium Content
Welcome Back! Please Log In to Continue.
X
Enter your credentials below to log in. Not yet a member of Pharmaceutical Online? Subscribe today.
Subscribe to Pharmaceutical Online
X
Subscribe to Pharmaceutical Online
Parenteral Drug Association (PDA)
This website uses cookies to ensure you get the best experience on our website. Learn more